Press Releases

Dec 14, 2020

PharmaCyte Biotech Begins Physical Testing of CypCaps in Response to FDA Recommendations for its Clinical Trial Product

Dec 2, 2020

PharmaCyte Biotech Successfully Completes 9-Month Stability Study

Nov 4, 2020

PharmaCyte Biotech Receives U.S. FDA Clinical Hold Letter

Oct 2, 2020

PharmaCyte Biotech’s Investigational New Drug Application Placed on Hold by the U.S. FDA

Sep 23, 2020

PharmaCyte Biotech Continues to Engage the FDA During 30-Day Comment Period

Sep 14, 2020

PharmaCyte Biotech Successfully Completes Six-Month Stability Study

Sep 8, 2020

PharmaCyte Biotech Successfully Completes Second Container Closure Integrity Test

Sep 2, 2020

PharmaCyte Biotech Announces IND Submitted to U.S. FDA for Clinical Trial in Locally Advanced, Inoperable Pancreatic Cancer

Aug 10, 2020

PharmaCyte Biotech Appoints Dr. José Iglesias as Consulting Chief Medical Officer for Clinical Trial in Pancreatic Cancer

Aug 5, 2020

FDA Formally Accepts PharmaCyte Biotech’s Drug Master File for Company’s Pancreatic Cancer Therapy